Literature DB >> 22391649

Molecular aspects of prostate cancer.

M V Cronauer, Z Culig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22391649     DOI： 10.1007/s00345-012-0853-x

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  11 in total

Review 1.  Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer.

Authors:  Marianne D Sadar
Journal:  World J Urol       Date:  2011-08-11       Impact factor: 4.226

Review 2.  Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.

Authors:  Nagalakshmi Nadiminty; Allen C Gao
Journal:  World J Urol       Date:  2011-10-19       Impact factor: 4.226

3.  ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Authors:  Anna Vinarskaja; Wolfgang Goering; Marc Ingenwerth; Wolfgang A Schulz
Journal:  World J Urol       Date:  2011-09-01       Impact factor: 4.226

4.  AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells.

Authors:  Wolfgang Streicher; Friedemann Zengerling; Martin Laschak; Wolfgang Weidemann; Michael Höpfner; Andres J Schrader; Florian Jentzmik; Mark Schrader; Marcus V Cronauer
Journal:  World J Urol       Date:  2012-02-24       Impact factor: 4.226

5.  Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.

Authors:  Matthias B Stope; Tina Schubert; Doreen Staar; Cindy Rönnau; Andreas Streitbörger; Nils Kroeger; Constanze Kubisch; Uwe Zimmermann; Reinhard Walther; Martin Burchardt
Journal:  World J Urol       Date:  2012-02-24       Impact factor: 4.226

Review 6.  NF-κB signaling in prostate cancer: a promising therapeutic target?

Authors:  Garima Jain; Marcus V Cronauer; Mark Schrader; Peter Möller; Ralf B Marienfeld
Journal:  World J Urol       Date:  2011-11-16       Impact factor: 4.226

7.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

8.  Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.

Authors:  Rong Hu; Thomas A Dunn; Shuanzeng Wei; Sumit Isharwal; Robert W Veltri; Elizabeth Humphreys; Misop Han; Alan W Partin; Robert L Vessella; William B Isaacs; G Steven Bova; Jun Luo
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

9.  Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.

Authors:  Xiaotun Zhang; Colm Morrissey; Shihua Sun; Melanie Ketchandji; Peter S Nelson; Lawrence D True; Funda Vakar-Lopez; Robert L Vessella; Stephen R Plymate
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

Review 10.  Androgen receptor footprint on the way to prostate cancer progression.

Authors:  Myles C Hodgson; Wayne A Bowden; Irina U Agoulnik
Journal:  World J Urol       Date:  2011-09-17       Impact factor: 4.226
View more
  2 in total

1.  Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.

Authors:  Anbalagan Jaganathan; Pratima Chaurasia; Guang-Qian Xiao; Marc Philizaire; Xiang Lv; Shen Yao; Kerry L Burnstein; De-Pei Liu; Alice C Levine; Shiraz Mujtaba
Journal:  Mol Endocrinol       Date:  2014-04-04

2.  Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.

Authors:  Julia Roediger; Wiebke Hessenkemper; Sophie Bartsch; Marina Manvelyan; Soeren S Huettner; Thomas Liehr; Mohsen Esmaeili; Susan Foller; Iver Petersen; Marc-Oliver Grimm; Aria Baniahmad
Journal:  Mol Cancer       Date:  2014-09-12       Impact factor: 27.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.